Reassuring Findings Regarding Oral Bisphosphonates and Esophageal Cancer (08/23/2010)
Oral bisphosphonates—drugs commonly used to prevent or treat osteoporosis—do not appear to increase the risk of esophageal cancer. These results were published in the Journal of the American Medical Association.

High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (07/12/2010)
High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma.

Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) (05/28/2010)
An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations were recently published in the Journal of the National Cancer Institute.

Depression May Persist With Metastatic Cancer (05/27/2010)
A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.

Less Extensive Treatment Doesn’t Worsen Survival with Early Esophageal Cancer (09/04/2009)
Among patients with esophageal adenocarcinoma that involves only the innermost lining (mucosa) of the esophagus, treatment to remove just the cancer appears to result in similar overall survival as treatment that removes the entire esophagus. These results were published in Gastroenterology.

Scalding Hot Tea May Increase the Risk of Esophageal Cancer (04/06/2009)
Individuals who drink scalding hot tea may have as much as eight times the risk of developing esophageal cancer compared with individuals who consume their tea warm or lukewarm. The results of this study were published in the British Medical Journal.